Loading clinical trials...
Loading clinical trials...
A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
Conditions
Interventions
BION-1301 Single Dose
Placebo Single Dose
+3 more
Locations
16
United States
Amicis Research Center
Northridge, California, United States
Colorado Kidney Care, P.C.
Denver, Colorado, United States
Nephrology Associates of Central Florida
Orlando, Florida, United States
Elixia Tampa, LLC
Tampa, Florida, United States
New York Nephrology
Clifton Park, New York, United States
Chris Sholer, P.C.
Oklahoma City, Oklahoma, United States
Start Date
April 8, 2019
Primary Completion Date
October 1, 2025
Completion Date
April 13, 2026
Last Updated
April 13, 2025
NCT05797610
NCT05234463
NCT06740526
NCT06767592
NCT06065852
NCT03001947
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions